The potential association between higher tumor expression of CD44 and overall poor prognosis in patients with glioma could be explained by the roles of CD44 in the proliferation, invasion, metastasis of glioma, and resistance to chemotherapy and radiation therapy [24]. This evidence concerns the gene CD44 and neoplasm.